Phase
Condition
Dementia
Memory Loss
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
Ages 40-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants undergoing cardiac surgery: coronary artery bypass grafting, heart valvesurgery or a combined procedure,
Procedure must be elective
Exclusion
Exclusion Criteria:
Symptomatic cerebrovascular disease,
Cerebrovascular incident in last 3 years,
Neurodegenerative disease,
Psychiatric disease,
Visual, hearing or motor impairment interfering with cognitive testing,
Carotid artery stenosis ( ≥50%),
Myocardial infarction within last 3 months,
Left ventricular ejection fraction of ≤35%,
Previous cardiac or carotid surgery,
Uncontrolled systemic hypertension (blood pressure≥180/110 mmHg),
Corticosteroid-dependent asthma,
Chronic obstructive pulmonary disease (COPD),
Malignancy, liver disease (aspartate transaminase (AST), alanine transaminase (ALT) orbilirubin ˃1.5x above reference range),
Kidney disease (serum creatinine ˃1.7 mg/dl or blood urea nitrogen ˃50 mg/dL),
Uncontrolled diabetes mellitus (postprandial glucose ˃200 mg/dL or hemoglobin A1c ˃9%),
Endocrine and metabolic diseases, requiring steroid treatment longer than 7 days inthe past year,
Alcohol or controlled substance abuse,
Individuals without primary school education,
Preoperative C reactive protein ˃0.5 mg/dL,
Preoperative white blood cell count <3 x109/L or ˃11 x109/L,
Preoperative Mini mental score <26 points,
Preoperative Beck's depression inventory score ˃ 19 points,
Intraoperative plan change (conversion from "off-pump" to "on-pump" and vice versa),
Need for deep hypothermic circulatory arrest,
Additional corticosteroid treatment throughout the study period.